Erectile Dysfunction in Qatar: Prevalence and Risk Factors in 1,052 Participants—A Pilot Study  by Al Naimi, Abdulla et al.
ORIGINAL RESEARCH—EPIDEMIOLOGY
Erectile Dysfunction in Qatar: Prevalence and Risk Factors in
1,052 Participants—A Pilot Study
Abdulla Al Naimi, MD, Ahmad A. Majzoub, MD, Raidh A. Talib, MD, Onder Canguven, MD, and
Abdulla Al Ansari, MD
Department of Urology, Hamad Medical Corporation, Doha, Qatar
DOI: 10.1002/sm2.26
A B S T R A C T
Aim. The aim of this study is to investigate the prevalence of erectile dysfunction (ED) in Qatar and to determine
the risk factors associated with it.
Materials andMethods. This is a cross-sectional survey study of men attending the outpatient department at Hamad
Medical Corporation in Qatar between February 2012 and February 2013. The International Index of Erectile
Function (IIEF)-5 questionnaire was used for data collection. In addition to the IIEF-5 score, each participant’s
medical history was taken, with special emphasis on risk factors for ED, including diabetes mellitus (DM), hyper-
tension (HTN), dyslipidemia, coronary artery disease (CAD), and smoking habits, and on their body mass index.
Results. One thousand ﬁfty-two participants were randomly selected to ﬁll out the IIEF-5 questionnaire. The
participants’ mean age (±SD) was 41.87 ± 13.24 years. Analysis of replies to the IIEF-5 showed that ED was present
in 573 out of 1,052 participants (54.5%). Fifty-six (5%) participants had severe ED, 61 (6%) had moderate ED, 173
(16%) had mild to moderate ED, and 283 (27%) had mild ED. Risk factors for ED that held statistical signiﬁcance
were age (odds ratio [OR] = 2.9, 95% conﬁdence interval [CI] 2.1–4.1, P < 0.001), DM (OR = 2.6, 95% CI 1.7–3.9,
P < 0.001), HTN (OR = 1.6, 95% CI 1.1–2.5, P = 0.012), dyslipidemia (OR = 1.5, 95% CI 1.1–2.4, P = 0.024), and
CAD (OR = 3.2, 95% CI 1.3–7.5, P = 0.009).
Conclusion. We found that the prevalence rate of ED in Qatar is quite similar to the regional reported rates. Overall,
we demonstrated that nearly more than half of our participants suffered from ED. Besides age, DM, HTN, CAD,
and dyslipidemia were found to be the most important risk factors for ED. Al Naimi A, Majzoub AA, Talib RA,
Canguven O, and Al Ansari A. Erectile dysfunction in Qatar: Prevalence and risk factors in 1,052
participants—A pilot study. Sex Med 2014;2:91–95.
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Introduction
Erectile dysfunction (ED) is a frequent problemin aging men [1,2]. Several studies have been
carried out worldwide to establish the prevalence of
ED [1–9]. In 1995, it was estimated that ED affected
around 152 million men worldwide, with projections
that this number could increase to 322 million by
2025 [2]. ED prevalence has been reported as 52%
in the USA [1], 34% in Australia [3], 26% in Japan
[4], 19.2% in Germany [5], and 12% in China [6].
Reports from Middle Eastern countries showed
a prevalence rate of 63.6% in Egypt [7], 54% in
Morocco [8], and 49.9% in Jordan [9]. This reported
variation in the prevalence of ED might be attri-
buted to regional and cultural differences of ED
perception, the age of the population, and/or the
extent of comorbid conditions.
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The etiology of ED has been studied compre-
hensively and found to be multifactorial. Chronic
diseases including hypertension (HT), diabetes
mellitus (DM), and coronary artery disease (CAD),
as well as adverse effects of treatments used for
these conditions, are known to constitute major
causes of ED [10]. Previous studies have veriﬁed
that greater age is strongly associated with ED
[7,10]. This issue is mainly attributed to the
occurrence of degenerative changes resulting in
endothelial dysfunction [8]. Furthermore, physi-
ological alterations related to hormonal changes
and sedentary lifestyle have also been implicated
among the causes of ED [10,11]. It has also been
reported that psychological problems, such as
depression, performance anxiety, and relationship
problems, may be both complications and risk
factors of ED [12].
ED is still underestimated in many developing
countries [8,13], probably because it is not a life-
threatening condition and those who have it likely
tend not to disclose it. The majority of patients
with ED suffer from low self-esteem and feel
isolated because they are unable to discuss this
sensitive issue with their physician for fear of
embarrassment [14]. ED has been reported to have
a detrimental effect on all levels of intimacy—
emotional, social, sexual, recreational and intel-
lectual [15,16]. Furthermore, ED patients have a
decreased quality of life [12]. Therefore, there is
need to address this social health problem.
The aim of this study was to explore the preva-
lence of ED in Qatar utilizing the International
Index of Erectile Function (IIEF)-5 questionnaire.
Investigating the prevalence of ED in our popula-
tion is motivating. Qatar is a small country in the
Middle East with lifestyle and cultural distinctions
that could inﬂuence the study results. A diet rich in
proteins and fat, together with a prevailing seden-
tary lifestyle, have resulted in a high incidence
of obesity and DM in the country. We hypoth-
esized that the prevalence of ED in Qatar would
be higher than what has been reported in Western
nations. On the other hand, discussing sexual func-
tion is not easy, as the cultural upbringing of men
in Qatari society makes it uncomfortable for them
to raise such a sensitive issue.
Materials and Methods
This study was carried out in a tertiary teaching
hospital located in Doha, Qatar. The hospital is
the only referral health center in the country,
serving a population of around 2 million people. A
non-probability purposive sampling technique was
utilized during selection of participants. These
subjects were patients or their companions pre-
senting to the outpatient department of the hospi-
tal. Men aged 20–70 years were included. During
recruitment the participants were asked if they
could contribute to a study of erectile function
in Qatar. All the participants in the study were
married and living with spouses. Moreover, par-
ticipants were asked ﬁve questions about their past
and present illnesses, followed by ﬁlling out of the
IIEF-5 questionnaire in a conﬁdential designated
area.
The IIEF-5 is a brief, reliable, and valid self-
administered questionnaire containing ﬁve ques-
tions that has been widely used in many countries
to detect the presence and severity of ED [17].
Erectile function was classiﬁed according to
IIEF-5 score: severe ED (0–7), moderate ED
(8–11), mild to moderate ED (12–16), mild ED
(17–21), and no ED (22–25). In addition to the
IIEF-5 score, each participant’s medical history
was taken, with special emphasis on risk factors for
ED, including DM, HT, dyslipidemia, CAD, and
smoking habits, and on body weight and height.
This study was conducted in accordance
with the principles laid down by the 18th World
Medical Assembly (Helsinki, 1964) and all appli-
cable amendments laid down by the World
Medical Assemblies and the International Con-
ference on Harmonization guidelines for good
clinical practice. In addition, the institutional
review board approved the study. All participants
provided consent and were informed to the fullest
extent possible about the study in language and
terms they were able to understand.
The prevalence of ED was calculated by divid-
ing the number of patients with ED by the total
number of patients. The risk factors for ED were
studied by calculation of the odds ratio (OR).
Univariate analysis was conducted using anova for
continuous variables and the χ2-test for catego-
rical variables. Variables that showed signiﬁcance
in univariate analysis were studied by multivariate
logistic regression to determine independent vari-
ables affecting ED. All men reporting ED with the
IIEF-5 (regardless of severity) were included in the
univariate and multivariate analysis. The statistical
analysis of the collected data was performed using
SPSS version 19.0 (IBM, Armonk, NY, USA).
Results
Between February 2012 and February 2013, 1,052
participants were included in this study. IIEF-5
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responses revealed that 56 participants had severe
ED (5%), 61 had moderate ED (6%), 173 had
mild to moderate ED (16%), and 283 had mild ED
(27%) (Figure 1). The participants’ demogra-
phic data and the distribution and severity of ED
among different age groups are presented in
Table 1 and Figure 2, respectively.
The results of the univariate analysis of risk
factors of ED are shown in Table 2. One hundred
seventy-two participants (30%) had DM (P <
0.001); 143 (24.9%) had HT (P < 0.001); 111
(19.3%) had dyslipidemia (P < 0.001); 50 (8.7%)
had CAD (P < 0.001); and 124 (21.6%) were
smokers (P < 0.001).
Multivariate logistic regression analysis was
performed and showed the risk factors that held
statistical signiﬁcance to be age (OR = 2.9, 95%
CI 2.1–4.1), DM (OR = 2.6, 95% CI 1.7–3.9),
HT (OR = 1.6, 95% CI 1.1–2.5), dyslipidemia
(OR = 1.5, 95% CI 1.05–2.4), and CAD (OR =
3.2, 95% CI 1.3–7.5). Smoking (OR = 0.6, 95% CI
0.4–0.8) and body mass index (OR = 0.7, 95% CI
0.5–0.9) were not proven to be statistically signiﬁ-
cant risk factors for ED. Among the variables asso-
ciated with ED, age was the most important and
the only factor that had an impact on the severity
of ED (Table 3).
Discussion
This study shows that ED is common in our
population, with a prevalence rate of 54.5%. Our
reports are consistent with the results of other
ED prevalence studies held in our region [7–9].
ED and its risk factors have been studied in
several Middle Eastern countries. In a study by
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Figure 1 International Index of Erectile Function (IIEF)-5
questionnaire results. Severe ED = 0–7; moderate ED =
8–11; mild to moderate ED = 12–16; mild ED = 17–21; no
ED = 22–25.
Table 1 Demographic data of the study participants
Age (years), mean ± SD 41.87 ± 13.24
Diabetes mellitus, n (%) 209 (19.9)
Hypertension, n (%) 187 (17.8)
Dyslipidemia, n (%) 157 (14.9)
Coronary artery disease, n (%) 57 (5.4)
Smoking, n (%) 277 (26.3)
Body mass index (kg/m2), mean ± SD 29.1 ± 13.11
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Figure 2 Erectile dysfunction (ED) severity among various
age groups based on results of the International Index of
Erectile Function (IIEF)-5 questionnaire. Severe ED = 0–7;
moderate ED = 8–11; mild to moderate ED = 12–16; mild
ED = 17–21; no ED = 22–25.
Table 2 Univariate analysis of risk factors of erectile
dysfunction
Risk factor ED No ED P value
Age (years), mean ± SD 46.6 ± 14.4 36.2 ± 8.7 <0.001
Diabetes mellitus, n (%) 172 (30) 37 (7.7) <0.001
Hypertension, n (%) 143 (25) 44 (9.2) <0.001
Dyslipidemia (%) 111 (19.4) 46 (9.6) <0.001
Coronary artery disease,
n (%)
50 (8.7) 7 (1.5) <0.001
Smoking (%) 124 (21.6) 153 (31.9) <0.001
Body mass index (kg/m2),
mean ± SD
29.8 ± 16.9 28.15 ± 5.57 0.07
Table 3 Multivariate analysis of risk factors of erectile
dysfunction
Adjusted
odds ratio
95%
confidence
interval P value
Age 2.9 2.1–4.1 <0.001
Diabetes mellitus 2.6 1.7–3.9 <0.001
Hypertension 1.6 1.1–2.5 0.012
Dyslipidemia 1.5 1.05–2.4 0.027
Coronary artery disease 3.2 1.3–7.5 0.009
Smoking 0.6 0.4–0.8 0.006
Body mass index 0.7 0.5–0.9 0.08
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Shaeer et al., a global online sexuality survey
was utilized to assess ED among Arabic-speaking
Internet users in the Middle East [10]. Of the 804
male respondents, there was a collective ED preva-
lence rate of 47%, with a higher prevalence among
those who were positive for risk factors such as HT
and DM. In another study from Jordan [9], a total
of 905 men aged 18 years old and above responded
to the IIEF-5 questionnaire, in addition to ques-
tions about their medical history, lifestyle habits,
and sexual behavior. According to the latter study,
the prevalence of all degrees of ED was 49.9%,
with age being the single most signiﬁcant risk
factor [9].
Increasing age is correlated with both increas-
ing prevalence of ED overall and increasing sever-
ity. The Massachusetts Male Aging Study found
that age was the variable most strongly associated
with ED [1]. At age 40, approximately 40% of men
are affected, and this rate increases to nearly 70%
in men aged 70 years [1]. Proposed reasons for this
association have included an age-related decline in
sex hormones in addition to degenerative changes
resulting in endothelial dysfunction [11,12].
Our study also analyzed known ED risk factors
in our community. ED has been shown to be more
prevalent among diabetic individuals, with pre-
valence ranging from 35% to 75% [18,19]. Qatar
is ranked ﬁfth in percentage of people between 20
and 79 years old with DM. Currently, 16% of the
population suffers from DM [20]. In our study, 172
out of 209 (82.2%) diabetic men reported ED.
Cardiovascular disease has also been linked to ED.
A study of middle-aged men showed that smoking,
obesity, and high serum lipids, being risk factors
for heart disease, were also linked with ED 25
years later [21]. On the other hand, in another
study it was reported that men with severe ED had
a risk ratio of 2 for development of cardiovas-
cular events [22]. This association is due to the
fact that ED is predominantly related to underly-
ing vascular causes, particularly atherosclerosis
[23]. Endothelial dysfunction is considered a key
pathophysiological cause of ED and cardiovascular
disease [23]. Therefore, early preventive inter-
vention should always be encouraged when ED
appears.
Our data showed that HT, dyslipidemia, and
CAD carried increased risk for developing ED,
with the highest risk being for CAD. In a systemic
review by Cao et al., smoking was found to
increase the risk of ED [24]. However, other
studies reported it to be less signiﬁcant [25]. In our
study population, smoking was not found to be a
statistically signiﬁcant risk factor for ED. Accord-
ing to the International Association for the Study
of Obesity, Qatar has the sixth highest rate of
obesity among boys in the Middle East and North
Africa. There is also controversy over the inﬂu-
ence of obesity on erectile function. Although
a negative inﬂuence of obesity on testosterone
synthesis, and hence libido and sexual function, is
expected, some studies have found no association
between obesity and ED [25,26]. In the present
study, obesity was not found to be a statistically
signiﬁcant risk factor for ED.
Understanding the prevalence of ED in any
community is a useful tool for estimation of the
magnitude of this problem and its related health
issues. ED might have major implications not only
for men’s relationships with their partners but also
with regard to their social/work environment; it is
a condition that may affect their productivity in
society. Our data support the null hypothesis that
there is no difference in ED prevalence between
Qatar and the rest of the world.
Although our study revealed important results
related to the prevalence and risk factors of ED,
it had some limitations. The main limitation of
our study was due to its design: Data collection
was carried out solely via a self-completed ques-
tionnaire rather than objective assessment. A
convenience sample was utilized that may not
be representative of all men in Qatar. Another
limitation of the research is that participants were
invited to participate in a study of erectile func-
tion; this may have skewed the population toward
men with erection issues, producing what might be
an overestimate of ED prevalence. Additionally,
because the majority of the population in Qatar
is composed of foreigners, this study may not
be a true reﬂection of the prevalence of ED
among Qatari nationals. Lastly, as we performed
this study in a hospital, we likely examined partici-
pants who had comorbidities and needed medical
treatment more than the average population.
Conclusion
ED is a common condition in Qatar, with a high
prevalence and severity that increases with age.
The correlates of ED identiﬁed in our popula-
tion are consistent with other previous studies
on the epidemiology of this sexual dysfunction.
The current ﬁndings conﬁrm previous observa-
tions about age, which was found to be the most
important factor that had an impact on the severity
of ED.
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